FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct

Journal of Child Neurology

Volumn 22, Issue 2, 2007, Pages 222-224

  Akar, Nejat ^a,b   Dönmez, Buket ^a   Deda, Gülhis ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Biotechnology Institute of Ankara University ^*  (Turkey)

Author keywords

Factor V; FXIII gene; Pediatric stroke; Prothrombin

Indexed keywords

BLOOD CLOTTING FACTOR 13; LEUCINE; VALINE;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN INFARCTION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; HETEROZYGOTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUROIMAGING; PRIORITY JOURNAL; RISK REDUCTION; STROKE; THROMBOSIS; TURKEY (REPUBLIC);

ADOLESCENT; CEREBRAL INFARCTION; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FACTOR XIII; FEMALE; HUMANS; INFANT; LEUCINE; MALE; POLYMORPHISM, GENETIC; TURKEY; VALINE;

EID: 34249860032     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807300309     Document Type: Article

References (26)

1. Anwar R., Stewart AD, Miloszewski KJ, Losowsky MS, Markham AF Molecular basis of inherited factor XIII deficiency: Identification of multiple mutations provides insights into protein function. Br J Haematol. 1995; 91: 728-735.
2. Suzuki K., Henke J., Iwata M., et al. Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene. Hum Genet. 1996; 98: 393-395.
3. Kohler HP, Ariens RA, Whitaker P., Grant PJ A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost. 1998; 80: 704.
4. Kangsadalampai S., Board PG The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood. 1998; 92: 2766-2770.
5. Anwar R., Gallivan L., Edmonds SD, Markham AF Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood. 1999; 93: 897-905.
6. Elbaz A., Poirier O., Canaple S., Chedru F., Cambien F., Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood. 2000; 95: 586-591.
7. Gemmati D., Serino ML, Ongaro A., et al. A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic disease. Am J Hematol. 2001; 67: 183-188.
8. Endler G., Funk M., Haering D., et al. Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol. 2003; 120: 310-314.
9. Corral J., Gonzalez-Conejero R., Iniesta JA, Rivera J., Martinez C., Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica. 2000; 85: 293-297.
10. Catto AJ, Kohler HP, Coore J., Mansfield MW, Stickland MH, Grant PJ Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood. 1999; 93: 906-908.
11. Renner W., Köppel H., Hoffmann C., et al. Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: Common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res. 2000; 99: 35-39.
12. Broderick J., Talbot T., Prenger E. Stroke in children within a major metropolitan area: The surprising importance of intracerebral hemorrhage. J Child Neurol. 1993; 8: 250-255.
13. Riela AR, Roach ES Etiology of stroke in children. J Child Neurol. 1993; 8: 201-220.
14. Akar N. Molecular approach to Turkish pediatric stroke patients. Turk J Hematol. 2002; 19: 245-253.
15. Nowak-Gottl U., Strater R., Dübbers A., et al. Ischemic stroke in infancy and childhood: Role of the Arg 506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis. 1996; 7: 684-688.
16. Ganesan V., McShane MA, Liesner R. Inherited prothrombotic states and ischemic stroke in childhood. J Neurol Neurosurg Psychiatry. 1998; 65: 508-511.
17. Akar N., Akar E., Deda G. Factor V 1691 G-A, prothrombin 20210G-A and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infant. J Child Neurol. 1999; 14: 749-751.
18. Bertina RM, Koeleman Rpc, Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369: 64-67.
19. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88: 3698-3703.
20. Akar N, Akar E, Dalgin G, Sözüöz A, Ömürlü K, Cin Ş. Frequency of factor V 1691 (G-A) mutation in Turkish population. Thromb Haemost. 1997; 78: 1527-1528.
21. Akar N., Misirlioǧlu M, Akar E, Avcu F, Yalçin A, Sözüöz A. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol. 1998; 58: 249.
22. McColl MD, Chalmers EA, Thomas A., et al. Factor V Leiden, prothrombin 20210 G-A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost. 1999; 81: 690-694.
23. Nowak-Göttl U., Strater R., Heinecke A., et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999; 94: 3678-3682.
24. Kenet G., Sadetzki S., Murat H., et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000; 31: 1283-1288.
25. Zens W., Bodo Z., Plotho J., et al. Factor V Leiden and prothrombin gene G20210 A variant in children with stroke. Thromb Haemost. 1998; 80: 763.
26. Akar N. Site specific mutagenesis: Usage for the mutation detection in thrombosis. Turk J Haematol. 1998; 15: 123-124.